Inventor · disambiguated record
Stephen Joseph Shuttleworth
Also filed as: SHUTTLEWORTH STEPHEN · SHUTTLEWORTH STEPHEN J · SHUTTLEWORTH STEPHEN JOSEPH
52 granted patents·15 pending applications·513 citations·filing 2002–2023
98Inventor score
Files withKARUS THERAPEUTICS LTD23HOFFMANN LA ROCHE9AMGEN INC6SHUTTLEWORTH STEPHEN JOSEPH5BAKER STEWART JAMES3
Top patents by PatentIndex Score
67 records- 0196US7781433B2Pharmaceutical compoundsPIRAMED LTD·Filed 2007·Granted Aug 24, 2010·83 cites·16 claims
- 0294US11291669B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentKARUS THERAPEUTICS LTD·Filed 2020·Granted Apr 5, 2022·4 cites·17 claims
- 0394US7750002B2Pharmaceutical compoundsPIRAMED LTD·Filed 2007·Granted Jul 6, 2010·37 cites·7 claims
- 0493US9200007B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Dec 1, 2015·22 cites·6 claims
- 0593US7776856B2Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 17, 2010·21 cites·7 claims
- 0692US11708378B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsCONVALIFE SHANGHAI CO LTD·Filed 2021·Granted Jul 25, 2023·2 cites·11 claims
- 0792US9981987B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted May 29, 2018·11 cites·14 claims
- 0892US8981087B2Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Mar 17, 2015·26 cites·11 claims
- 0991US10035785B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Jul 31, 2018·10 cites·17 claims
- 1091US9580442B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted Feb 28, 2017·14 cites·5 claims
- 1191US9266879B2Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory diseaseSHUTTLEWORTH STEPHEN JOSEPH·Filed 2011·Granted Feb 23, 2016·21 cites·13 claims
- 1291US7846929B2Phosphoinositide 3-kinase inhibitor compounds and methods of useGENENTECH INC·Filed 2007·Granted Dec 7, 2010·20 cites·57 claims
- 1391US7696204B2Pharmaceutical compoundsLUDWIG INST CANCER RES·Filed 2006·Granted Apr 13, 2010·27 cites·7 claims
- 1490US9938290B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Apr 10, 2018·11 cites·3 claims
- 1590US6887877B2Compounds and methods for the treatment or prevention of Flavivirus infectionsVIROCHEM PHARMA INC·Filed 2002·Granted May 3, 2005·45 cites·96 claims
- 1689US10668077B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentKARUS THERAPEUTICS LTD·Filed 2016·Granted Jun 2, 2020·4 cites·17 claims
- 1789US9663487B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·13 cites·15 claims
- 1889US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 1988US10513530B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 24, 2019·5 cites·19 claims
- 2088US10501478B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 10, 2019·5 cites·7 claims
- 2187US7872003B2Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2007·Granted Jan 18, 2011·7 cites·11 claims
- 2286US11779586B2Compounds comprising tricyclic heterocyclic compoundsCONVALIFE SHANGHAI CO LTD·Filed 2020·Granted Oct 10, 2023·2 cites·12 claims
- 2386US8450315B2Phosphoinositide 3-kinase inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2010·Granted May 28, 2013·10 cites·49 claims
- 2485US9340503B2Scriptaid isosteres and their use in therapyKARUS THERAPEUTICS LTD·Filed 2014·Granted May 17, 2016·7 cites·5 claims
- 2585US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 2684US10407435B2Diheteroaryl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Sep 10, 2019·6 cites·19 claims
- 2784US8748458B2Scriptaid isosteres and their use in therapySHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Jun 10, 2014·8 cites·18 claims
- 2884US8685968B2Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2012·Granted Apr 1, 2014·5 cites·6 claims
- 2983US8153639B2Substituted thieno- and furano- fused pyrimidines as PI3K inhibitorsCHUCKOWREE IRINA S·Filed 2007·Granted Apr 10, 2012·14 cites·17 claims
- 3082US10377764B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Aug 13, 2019·5 cites·2 claims
- 3181US10442815B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Oct 15, 2019·5 cites·20 claims
- 3281US10150763B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 11, 2018·3 cites·16 claims
- 3381US8946217B2Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Feb 3, 2015·3 cites·5 claims
- 3481US8324206B2Pharmaceutical compoundsCHUCKOWREE IRINA·Filed 2010·Granted Dec 4, 2012·7 cites·3 claims
- 3580US9862685B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2014·Granted Jan 9, 2018·4 cites·12 claims
- 3680US7572783B2Substituted benzofused heterocyclesAMGEN INC·Filed 2005·Granted Aug 11, 2009·3 cites·20 claims
- 3779US9676765B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2013·Granted Jun 13, 2017·4 cites·8 claims
- 3878US7358250B2Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activityAMGEN INC·Filed 2005·Granted Apr 15, 2008·4 cites·22 claims
- 3975US8101607B2Pharmaceutical compoundsSHUTTLEWORTH STEPHEN J·Filed 2010·Granted Jan 24, 2012·2 cites·10 claims
- 4073US8987260B2Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Mar 24, 2015·1 cites·2 claims
- 4173US8802670B2Pharmaceutical compoundsFOLKES Adrian·Filed 2007·Granted Aug 12, 2014·3 cites·12 claims
- 4271US12257254B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentCONVALIFE SHANGHAI CO LTD·Filed 2022·Granted Mar 25, 2025·0 cites·17 claims
- 4371US6809104B2Fused heterocyclic compoundsTULARIK INC·Filed 2002·Granted Oct 26, 2004·4 cites·38 claims
- 4470US8153629B2Pharmaceutical compoundsSHUTTLEWORTH STEPHEN J·Filed 2010·Granted Apr 10, 2012·1 cites·11 claims
- 4570US2020354378A1Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4667US10533003B2Polyheteroarl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Jan 14, 2020·1 cites·7 claims
- 4764US2025177393A1Modulators of myc family proto-oncogene proteinNALO THERAPEUTICS·Filed 2023·Application pending·0 cites
- 4863US2013317017A1Pharmaceutical compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4962US10870624B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 5062US2025170130A1Modulators of myc family proto-oncogene proteinNALO THERAPEUTICS·Filed 2023·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Joseph Shuttleworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →